Scott Reents
Director of Finance/CFO at TOBIRA THERAPEUTICS INC
Net worth: 3 M $ as of 30/03/2024
Profile
Scott T.
Reents is currently the President & Director at Allergan, Inc. and Oculeve, Inc. He is also the Chief Financial Officer & Executive Vice President at AbbVie, Inc. and the Chief Financial Officer at Tobira Therapeutics, Inc. Previously, he worked as the Vice President-Tax at Abbott Laboratories.
Mr. Reents completed his undergraduate degree at the University of Nebraska and holds graduate and MBA degrees from the University of Washington.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ABBVIE, INC.
0.00% | 27/02/2024 | 15,431 ( 0.00% ) | 3 M $ | 30/03/2024 |
Scott Reents active positions
Companies | Position | Start |
---|---|---|
TOBIRA THERAPEUTICS INC | Director of Finance/CFO | - |
ABBVIE INC. | Director of Finance/CFO | 22/06/2022 |
ALLERGAN, INC. | President | - |
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | President | - |
Former positions of Scott Reents
Companies | Position | End |
---|---|---|
ABBOTT LABORATORIES | Comptroller/Controller/Auditor | - |
Training of Scott Reents
University of Nebraska | Undergraduate Degree |
University of Washington | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
ABBVIE INC. | Health Technology |
Private companies | 3 |
---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | Health Technology |
Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on October 6, 2006 and is headquartered in Madison, NJ. | Health Technology |
- Stock Market
- Insiders
- Scott Reents